Career history of Yaping Shou
Former positions of Yaping Shou
Companies | Position | Start | End |
---|---|---|---|
TRILLIUM THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2018-04-22 | 2020-11-01 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2011-09-30 | 2018-05-31 |
Training of Yaping Shou
Drexel University College of Medicine | Doctorate Degree |
Zhejiang University School of Medicine | Doctorate Degree |
University of Pennsylvania | Doctorate Degree |
Statistics
International
United States | 4 |
Canada | 2 |
China | 2 |
Operational
Doctorate Degree | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Trillium Therapeutics ULC
Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Yaping Shou
- Experience